Abstract:280 Background: Prostate cancer is characterized by heterogeneity of mechanisms which are poorly understood but pointing to epithelial plasticity as the key mechanism in progression to metastatic disease. ABI1, a member of WAVE complex and actin cytoskeleton regulator and adaptor protein, is proposed to act as tumor suppressor in prostate cancer, but the mechanism of tumor progression due to Abi1 loss is not clear. Methods: To address Abi1’s role in prostate cancer we used CRISPR-based gene editing and retroviral expression to manipulate Abi1 levels in prostate cancer cell lines. Levels of Abi1 expression in prostate organoid tumor cell lines were evaluated by Western blotting and/or RNA sequencing. Association of Abi1 loss with tumor grade was evaluated by immunohistochemistry. Results: Abi1 expression is downregulated in tumor organoid cell lines from metastatic bone and lymph node biopsies. Moreover, low Abi1 expression is associated with high-grade prostate tumors (GG3 or higher, p < 0.001). Disruption of Abi1 gene in a benign prostate epithelial cell line RWPE-1 resulted in a gain of invasive phenotype, which is characterized by loss of cell-cell adhesion markers and increased migratory ability of RWPE-1 Abi1 KO spheroids. Through RNA sequencing and protein expression analysis we discovered that Abi1 loss leads to activation of non-canonical WNT signaling and EMT pathways, which are rescued by re-expression of Abi1. Furthermore, increase in STAT3 phosphorylation upon Abi1 inactivation and evidence for high affinity interaction of FYN-SH2 domain with Abi1 pY421 support the model that Abi1 acts as a gatekeeper of the non-canonical WNT-EMT pathway activation downstream from FZD2 receptor. The gene expression profile of Abi1-EMT-WNT pathway overlaps with the reported gene signature of high-risk prostate tumors. Conclusions: Abi1 contributes to prostate cancer progression and epithelial plasticity through regulation of EMT-WNT pathways. Understanding of Abi1’s role may provide more mechanistic understanding of prostate cancer tumor progression.

The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis

Abl Interactor 1 Regulates Src-Id1-matrix Metalloproteinase 9 Axis and is Required for Invadopodia Formation, Extracellular Matrix Degradation and Tumor Growth of Human Breast Cancer Cells

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

Abi1 Gene Silencing by Short Hairpin RNA Impairs Bcr-Abl-induced Cell Adhesion and Migration in Vitro and Leukemogenesis in Vivo

Bcr-Abl Induces Abnormal Cytoskeleton Remodeling, Β1 Integrin Clustering and Increased Cell Adhesion to Fibronectin Through the Abl Interactor 1 Pathway

ABL Kinases Promote Breast Cancer Osteolytic Metastasis by Modulating Tumor-Bone Interactions Through TAZ and STAT5 Signaling

Abi1 Loss Drives Prostate Tumorigenesis Through Activation of EMT and Noncanonical WNT Signaling.

Inactivation of ABL kinases suppresses non-small cell lung cancer metastasis.

Development of Abl Interactor Protein 1 on Basic and Clinical Research of Oncology

ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling

The N-terminal Domain of the Non-Receptor Tyrosine Kinase ABL Confers Protein Instability and Suppresses Tumorigenesis

CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway

Abelson interactor 1 splice isoform-L plays an anti-oncogenic role in colorectal carcinoma through interactions with WAVE2 and full-length Abelson interactor 1

EXPRESSIONS OF ABI1,c-ABL AND WAVE2 PROTEIN IN BREAST CANCER AND THEIR CORRELATIONS

AMBRA1 Promotes TGF{beta} Signaling via Nonproteolytic Polyubiquitylation of Smad4

AMBRA1 Promotes TGFβ Signaling Via Nonproteolytic Polyubiquitylation of Smad4.

Regulation of cell death by the Abl tyrosine kinase

Important role of C-Abl in tumor occurrence and treatment

Adaptor protein Abelson interactor 1 in homeostasis and disease

The c-Cbl Ubiquitin Ligase Regulates Nuclear β-Catenin and Angiogenesis by Its Tyrosine Phosphorylation Mediated through the Wnt Signaling Pathway*

C-Abl Regulates Estrogen Receptor Α Transcription Activity Through Its Stabilization by Phosphorylation